Healthcare Realty Trust Incorporated (HR)
NYSE: HR · Real-Time Price · USD
15.98
+0.28 (1.78%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Healthcare Realty Trust Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Healthcare Realty Trust stock have an average target of 17, with a low estimate of 16 and a high estimate of 19. The average target predicts an increase of 6.38% from the current stock price of 15.98.
Analyst Consensus: Sell
* Price targets were last updated on Mar 10, 2025.
Analyst Ratings
The average analyst rating for Healthcare Realty Trust stock from 5 stock analysts is "Sell". This means that analysts believe this stock is likely to lead to lower returns than market as a whole.
Recommendation Trends
Rating | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 | Apr '25 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 0 | 0 | 0 | 0 | 0 |
Buy | 1 | 0 | 0 | 0 | 0 | 0 |
Hold | 5 | 5 | 4 | 2 | 2 | 2 |
Sell | 1 | 1 | 2 | 2 | 3 | 3 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 8 | 6 | 6 | 4 | 5 | 5 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Wells Fargo | Wells Fargo | Sell Maintains $17 → $16 | Sell | Maintains | $17 → $16 | +0.13% | Mar 10, 2025 |
Scotiabank | Scotiabank | Hold Maintains $18 → $17 | Hold | Maintains | $18 → $17 | +6.38% | Feb 25, 2025 |
Wedbush | Wedbush | Hold → Sell Downgrades $18 → $16 | Hold → Sell | Downgrades | $18 → $16 | +0.13% | Jan 2, 2025 |
JP Morgan | JP Morgan | Buy → Hold Downgrades $19 | Buy → Hold | Downgrades | $19 | +18.90% | Dec 20, 2024 |
Wells Fargo | Wells Fargo | Sell Initiates $16 → $17 | Sell | Initiates | $16 → $17 | +6.38% | Oct 1, 2024 |
Financial Forecast
Revenue This Year
1.24B
from 1.27B
Decreased by -2.30%
Revenue Next Year
1.27B
from 1.24B
Increased by 2.42%
EPS This Year
-0.34
from -1.81
EPS Next Year
-0.36
from -0.34
Revenue Forecast
Revenue | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 1.3B | 1.3B | 1.3B | |
Avg | 1.2B | 1.3B | 1.2B | |
Low | 1.1B | 1.1B | 1.2B |
Revenue Growth
Revenue Growth | 2025 | 2026 | 2027 | 2028 |
---|---|---|---|---|
High | 3.5% | 8.4% | -0.3% | |
Avg | -2.3% | 2.4% | -2.9% | |
Low | -10.9% | -7.7% | -8.3% |
EPS Forecast
EPS | 2025 | 2026 | 2027 |
---|---|---|---|
High | -0.17 | -0.29 | -0.34 |
Avg | -0.34 | -0.36 | -0.33 |
Low | -0.46 | -0.44 | -0.31 |
EPS Growth
EPS Growth | 2025 | 2026 | 2027 |
---|---|---|---|
High | - | - | - |
Avg | - | - | - |
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.